16-88733731-C-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001142864.4(PIEZO1):​c.2344G>A​(p.Gly782Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00514 in 1,545,466 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0040 ( 2 hom., cov: 34)
Exomes 𝑓: 0.0053 ( 33 hom. )

Consequence

PIEZO1
NM_001142864.4 missense

Scores

6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:5

Conservation

PhyloP100: 3.99
Variant links:
Genes affected
PIEZO1 (HGNC:28993): (piezo type mechanosensitive ion channel component 1 (Er blood group)) The protein encoded by this gene is a mechanically-activated ion channel that links mechanical forces to biological signals. The encoded protein contains 36 transmembrane domains and functions as a homotetramer. Defects in this gene have been associated with dehydrated hereditary stomatocytosis. [provided by RefSeq, Jul 2015]
ENSG00000224888 (HGNC:56095): (HSP90AB1 associated lncRNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011941671).
BP6
Variant 16-88733731-C-T is Benign according to our data. Variant chr16-88733731-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 242665.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=4}. Variant chr16-88733731-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00402 (612/152324) while in subpopulation NFE AF= 0.00625 (425/68020). AF 95% confidence interval is 0.00576. There are 2 homozygotes in gnomad4. There are 269 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 612 AD,BG gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIEZO1NM_001142864.4 linkc.2344G>A p.Gly782Ser missense_variant Exon 18 of 51 ENST00000301015.14 NP_001136336.2 Q92508
HSALR1NR_103774.1 linkn.269+2283C>T intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIEZO1ENST00000301015.14 linkc.2344G>A p.Gly782Ser missense_variant Exon 18 of 51 1 NM_001142864.4 ENSP00000301015.9 Q92508
ENSG00000224888ENST00000440406.2 linkn.269+2283C>T intron_variant Intron 1 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.00402
AC:
612
AN:
152206
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000989
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00790
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00625
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00381
AC:
554
AN:
145236
Hom.:
5
AF XY:
0.00376
AC XY:
293
AN XY:
78020
show subpopulations
Gnomad AFR exome
AF:
0.000863
Gnomad AMR exome
AF:
0.00108
Gnomad ASJ exome
AF:
0.00312
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00100
Gnomad FIN exome
AF:
0.00817
Gnomad NFE exome
AF:
0.00627
Gnomad OTH exome
AF:
0.00264
GnomAD4 exome
AF:
0.00526
AC:
7329
AN:
1393142
Hom.:
33
Cov.:
32
AF XY:
0.00507
AC XY:
3484
AN XY:
686826
show subpopulations
Gnomad4 AFR exome
AF:
0.000761
Gnomad4 AMR exome
AF:
0.00130
Gnomad4 ASJ exome
AF:
0.00302
Gnomad4 EAS exome
AF:
0.0000280
Gnomad4 SAS exome
AF:
0.000992
Gnomad4 FIN exome
AF:
0.00949
Gnomad4 NFE exome
AF:
0.00591
Gnomad4 OTH exome
AF:
0.00493
GnomAD4 genome
AF:
0.00402
AC:
612
AN:
152324
Hom.:
2
Cov.:
34
AF XY:
0.00361
AC XY:
269
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.000986
Gnomad4 AMR
AF:
0.00157
Gnomad4 ASJ
AF:
0.00346
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00790
Gnomad4 NFE
AF:
0.00625
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00548
Hom.:
1
Bravo
AF:
0.00342
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.00415
AC:
16
ExAC
AF:
0.00198
AC:
54
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:4
Nov 11, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

BS2, BP4, PP1 -

-
Clinical Genetics, Academic Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 15, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

PIEZO1: BS2 -

not specified Uncertain:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Lymphatic malformation 6 Uncertain:1
May 28, 2019
Mendelics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

PIEZO1-related disorder Benign:1
Jul 23, 2019
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0069
T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.85
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Uncertain
2.5
M
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.18
Sift
Benign
0.41
T
Sift4G
Benign
0.57
T
Polyphen
1.0
D
Vest4
0.90
MVP
0.15
ClinPred
0.035
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.17
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200970763; hg19: chr16-88800139; COSMIC: COSV56333231; COSMIC: COSV56333231; API